Member Info for AB124

No, I was referring to Ratcliffewriter's Concerted Dormers!
:-)

It seems to me that Scancell have a (Dormer) window of opportunity over the next fifteen months or so to prove the value of the Commercial side, presupposing that there's no approach for the company in the meantime.
Since no one is saying that there's no possibilty of an early bid (at perhaps more than twice the current Share price) in the meantime it seems that the BOD MUST produce something that will tempt any suitor to pay more.
Not much wrong with that surely? there's plenty that would vote to accept that (and anyway even if they voted against they'd have an impossible fight on their hands if our one and a bit Hedge Funds decided they would be happy to accept (for reasons we probably would only undersatnd with hindsight).
Ball's firmly in the BOD's court in my view.
Let us hope they prove me wrong (and get the Shareprice to GBP1 plus before October 2022).
That's a reasonable challenge I would have thought. Chance for the Commercial whizzes on the BOD to really shine (after hiding their collective lights under a bushel for the last nine or so years)! We must remember that they have had the chance to commercialise the most cutting edge platforms available Globally since 2012, but with strangely no success.
Otherwise I guess an interim 50p offer will look attractive.
We can but wait and see.
AIMO

But RuckRover
Have you forgotten the Scancell Shell Company?
Could you get mine too?
LOL

Moonparty, Fair enough I respect your view.
It's great to be able to discuss, thanks for your contribution and open response.... Appreciated! :-)

Moonparty,
so even if redmile had an interest in a PROVEN Company that was prepared to take Scancell's IP on and expedite the development of the platforms in a more Bio friendly environment (maybe in the States) that it would leave Team Scancell to continue along its snail like trail to Commercialisation? they'd still get their potential profits but probably quicker.
Not so sure myself.
AIMO
I'm not so sure

RuckRover
I don't think that Redmile would be unaware of any T/O that came in. If they didn't like it I'm sure Counters could be produced well before any requirement to RNS arrived. If Redmile don't like it it ain't gonna happen IMV. In any case any offer that exceeds 13.5p is a profit of substance to them. I imagine that's where the DE comment about 22P came from. Do you think that Redmile wouldn't be in favour of any Offers over say 50p? I reckon they'd go straight through.
My point is (much as you have said) that they basically control the direction of Scancell and in the event of any takeover offer being made to Scancell involving a Redmile friendly offeror I would see their weoght being lined up in favour of the offer rather than against. In other words unless something unexpected arrived on the horizon (and any offeror knows what the vote count is/could be) then Redmile hold many or a very important number of the cards in the pack.
AIMO

RuckRover
From the scancell Fundraise Document Oct last year.
"The New Convertible Loan Notes are required to be redeemed on the Redemption Date which will be two
years after the date of execution of the Convertible Loan Note Instrument. The New Convertible Loan Notes
can be converted into Ordinary Shares at a conversion price of 13 pence per Ordinary Share. The Conversion
Price is subject to customary adjustments. Conversion is also subject to any Takeover Code restrictions
that may apply at the time of such Conversion. No Conversion can occur prior to the Redemption Date,
save for in the event of a takeover offer being made to shareholders of the Company or upon a Nasdaq
listing."
Note the exceptions to non conversion before maturity.
"...."save for in the event of a takeover offer being made to shareholders of the Company or upon a Nasdaq
listing."
Want to check the effect of Conversion of remaining CLNs?
AIMO

RR keep trying to get out to the garden but have you allowed for the remaining CLNs ?

Crumbs
Ref your ,
"AB ... I know Lindy knows the value of her platforms and is not going to be giving anything away"
The value is only what the present company can achieve, which to date is a blooming great (Controlling) interest by one and a bit Hedge funds.
I reckon that they can achieve the dreamed for value of Scancell rather than our current BOD who've had eight years to do it but even now (one year after the GBP50m injection) have failed to achieve anything reportable to their Private Investors! Quite a record!
Who would you say can achieve the CSO's dream of commercialising her Science?
Redmile or JC and co? I reckon another JC might achieve it but even then that would be a miracle!
IMO if LD wants her valuation of her IP realised it will be in a company other than Scancell or maybe Scancell merged into another larger more Dynamic sector operator where her dreams of realising her science can be matched with the appropriate financial rewards not only for her, but the new controlling Company their and the World at large.
The last sentence assumes Scancell isn't taken by a private Company which is even worse for us PIs in Scancell!
AIMO

RuckRover
Not that clever but I'd be surprised to see a private shareholder revolt at anything above 50p and even if there was and Vulpes/Redmile supported it (stranger things have happened) then it's a done deal. Think CLNs.
This might have had some bearing on DE's cooling and Expectation Management last year over the Fundraises (but I have nothing more than conjecture to support that comment and unreservedly apologise if I am incorrect).
I think that Scancell are driving themselves into the ground with lack of communication which erodes trust.
Let's face it the BOD haven't covered themselves in glory over the last nine years (even though LD continues to produce more and more cutting edge science which doesn't get near Commercialisation).
FWIW I don't think the Big holders can be beaten here and frankly I'd happily take anything North of 50p simply to get into a few shares in any company that takes them.
We also have had the incredibly (and I use that word advisedly) tight range of late.
I just wish I had a line into the likely/possible eventual destination of Scancell and its IP and CSO.
AIMO

Crumbs,
If we on the BB have identified the mismatch between the two areas of Scancell (as incorporated ATM) so will others.
if we agree that the Science is not being supported by the Commercial side with the same excellence as the Science then something has to be adjusted.
How about a substantial Pharma taking the whole of Scancell in one (cheap) hit.
Scancell has little leverage in terms of lack of data, a restless and dare I say put upon (private) investor base and a BOD where dynamism seems not to be a key part of the Corporate ethos.
Wouldn't it be just ripe for a takeover at a fraction of the value of the IP?
I can think of many who would see a lowball bid as an attractive (and profitable) way out of the turgid wait that Scancell has become, and who will happily support any cobbled together bid that will keep the IP in one place for (Proper and inspired) development whilst keeping the main Scientific asset (The sainted LD) connected to the IP.
Scancell BOD (in various shapes) have had their opportunity and as it's almost a year since THEY got minted - in terms of sufficient liquidity to further the IP - with as yet precious little news of data to be produced, my guess is that we'll be sold (not for 800p/share) sooner rather than later on a lock stock and barrel basis.
I had been thinking we had 15/16 months, but now I'm not so sure.
Hope I'm wrong but the shorter snapup looks like a good deal for some Biotech with Commercial drive and an ability to put togetrher a deal that looks attractive for the smaller investors!
AIMO

RayPointer
Ref your,
"I simply cannot understand the view of trying to rein in Lindy's talent for making new discoveries. It gives Scancell multiple shots on goal that they simply wouldn't have if they had put all their eggs in one basket. In any case I would guess that Lindy would be dead against such an approach."
But then,
"I do agree though that the management of the company does not match the calibre of the science. Scancell is way behind getting the data that the multiple scientific breakthroughs promise."
But your second point elaborates the first and so supports the concept that the Science has been let down by the Business.
Hence my comment,
"I wonder what would happen if LD were to resign?" which is an event I hope (and do not expect) to see, but it would be a logical extension of the two passages above with which you agree.
Back to waiting for some news (hopefully good and soon)!
AIMO

RayPointer
I would suggest that Prof. Durrant is very very good at research and developing new "Products".
The problem seems to be that she is much better at doing that than the rest of the BOD at bringing those new ideas out of the laboratory.
If when you say "But how is increasing the IP a problem?" it certainly was years ago when the entire business plan for Scancell was torpedoed by Moditope. I didn't raise this, you did.
IF (and all in hindsight) Moditope had not been part of the Scancell IP the original business plan would have been completed years ago ie Immunobody would (or would not )have been sold and Moditope could have formed the basis of a new company which would have been focussed on that platform.
I can't say that things would have turned out differently but neither can anyone not say that Moditope might already be developed and (since 2012) there would have been a great deal of time to have held trials which would not have been "shelved" due to lack of funds such as they have with SCLP.
So yes, in my view the BOD is failing the R and D and even more items added to the IP list here would not be good, unless something gets some cash in and then the BOD can be strengthened to actiually MOVE one of our wondrous platforms towards getting the Shareholders a return rather than merely stoking the hopes. and indulging the desire for more and more unproven (by trials) IP.
Anyway, there's effectively a line in the sand already so best they address what we have rather than complicating things with "more IP". I wonder whether the increase in IP has been part of the reason that RG was clever enough to avoid selling the company years ago?
It seems completely reasonable to say that NO Data = No commercialisation (unless we get sold for a relative pittance as a "punt" by a Pharma) or worse a hedge fund.
I wonder what would happen if LD were to resign?
However we can all wait patiently and see. Let's hope it works out as everyone here seems to think it will. I still live in hope.
AIMO

Ruck Rover
i agree, but rather more simply put the trial results will provide the data that will (or will not) prove the IP.
So my question to the BOD is simply,
"When do you think we will have one or more trials underway?"
It would be great if we the shareholders (and owners of the company) could be let in on the secret.
I'm happy to continue to take the risk, BUT it seems to me that we have around sixteen months for results, data and some indication of the likely outcome as a result of the Financial structure put in place last year.
Tempus fugit.
AIMO

Roses, no worries.
Simply vaguely remembered (I thought) that he had 10M+ shares... So I was wrong too!
Now NXC will prob post he was being modest and had 20M shares! LOL
All good stuff though.

RuckRover,
No worries.
Yes, if he took his full allocation then he would be within spitting distance of 10M shares (unless he was understating his appx holding).
So as far as we know he has (or had) substantially more Scancell than anyone else who posts on this BB.
There were so many vague and different views of his holding it seemed sensible to see what the man himself had to say.
As HRH QE said "Recollections may vary"!
Anyway wonder how long we hold the range!
AIMO

Falsedawn
Conversely imagine trying to sell 9.5m shares on the open market in one trade!
Seems likely that D E has been as good as his word.
AIMO

A partial quote from DE in October 2020.
"For my part I will be taking up the Open Offer re my holding of approx 9.5m shares and will continue to support the Company going forward."
Always better to find the evidence than rely on recollection perhaps.
So he had a reasonable holding in his own right.
Hope that clarifies....

Roses
I would agree with you; there should be no fuss..... Unless people feel that DE has stopped the SP rising (even you played down his holding to 1.5m) - but I'm not sure that's correct.
Having said that I think there's some very big fish at play here and the DE comments (although not to be dismissed) are a bit of a sideshow.
The bigger picture for me is the tightness of the recent trading range (and the way it was recovered from the highs on 9th June).
I believe that this range is highly significant. BUT as I wrote earlier when the fetters are off it could be explosive.
I'll wait and see, but every one / one and a half points upwards has been a very regular and profitable movement for someone or two. Why do I say that? Because all the excitement generated when the Shareprice firmed recently has seen the trading range restored, until the next little move up by a point or so...
AIMO

RatcliffeWriter
I'm not sure DE was, "no longer anything to do with Scancell".
He has/had interests in quite a lot of Scancell shares and so would undoubtedly have had discussions with the Company over his intended action.
DE may no longer be on the Board but he was very supportive of Scancell by way of his PR contacts last year.
Childish you may think, but he has (or will) make a great deal of profit from his holdings even if he sold all of them at this level. He's a very rich child if that is the case. I think he deserves a little more consideration, but that's purely my view and you are obviously entitled to your own ideas.
AIMO